UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

Endocrine-related cancer, 2009-12, Vol.16 (4), p.1197-1210

2009

Link zum Volltext

Verfügbarkeit prüfen

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

Breast (Edinburgh), 2016-08, Vol.28, p.191-198

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer

Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.743-753

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

Annals of oncology, 2013-03, Vol.24 (3), p.625-632

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer

British journal of cancer, 2010-10, Vol.103 (9), p.1335-1342

2010

Link zum Volltext

Verfügbarkeit prüfen

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

British journal of cancer, 2003-05, Vol.88 (10), p.1587-1591

2003

Link zum Volltext

Verfügbarkeit prüfen

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

The oncologist (Dayton, Ohio), 2015-08, Vol.20 (8), p.873-879

2015

Link zum Volltext

Verfügbarkeit prüfen

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Breast (Edinburgh), 2012-02, Vol.21 (1), p.20-26

2012

Link zum Volltext

Verfügbarkeit prüfen

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category

European journal of surgical oncology, 2007-02, Vol.33 (1), p.16-22

2007

Link zum Volltext

Verfügbarkeit prüfen

The use of breast cancer subtype classification to predict local and distant recurrence. A review

Cancer radiothérapie, 2008-11, Vol.12 (6-7), p.577-583

2008

Link zum Volltext

Verfügbarkeit prüfen

Typical medullary breast carcinomas have a basal/myoepithelial phenotype

The Journal of pathology, 2005-11, Vol.207 (3), p.260-268

2005

Link zum Volltext

Verfügbarkeit prüfen

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

Oncogene, 2001-09, Vol.20 (41), p.5810-5817

2001

Link zum Volltext

Verfügbarkeit prüfen

Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer

The International journal of biological markers, 2006-01, Vol.21 (1), p.20-29

2006

Link zum Volltext

Verfügbarkeit prüfen

Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene

International journal of oncology, 1999-04, Vol.14 (4), p.653

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome

International journal of oncology, 2003-06, Vol.22 (6), p.1319

2003

Link zum Volltext

Verfügbarkeit prüfen

Expression of fgf and fgf receptor genes in human breast cancer

International journal of cancer, 1995-04, Vol.61 (2), p.170-176

1995

Link zum Volltext

Verfügbarkeit prüfen

Low frequency of microsatellite instability in BRCA1 mutated breast tumours

Journal of medical genetics, 2000-10, Vol.37 (10), p.E32-32

2000

Link zum Volltext

Verfügbarkeit prüfen

Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability

International journal of oncology, 1998-06, Vol.12 (6), p.1373

1998

Link zum Volltext

Verfügbarkeit prüfen

Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations

Bulletin du cancer, 2004-12, Vol.91 Suppl 4, p.S205

2004

Link zum Volltext

Verfügbarkeit prüfen

Pgp immunochemistry: use with caution: correspondence re: C-H. Kao et al., P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res., 61: 1412-1414, 2001

Cancer research (Chicago, Ill.), 2002-01, Vol.62 (2), p.617-617

2002

Link zum Volltext

Verfügbarkeit prüfen

HER2 gene amplification assay: is CISH an alternative to FISH?

Annales de pathologie, 2003-12, Vol.23 (6), p.617

2003

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory breast carcinoma: towards molecular characterization?

Annales de pathologie, 2003-12, Vol.23 (6), p.564

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?

Annales de pathologie, 1999-04, Vol.19 (2), p.103

1999

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 induces major energetic metabolism reprogramming in breast cancer cells

PloS one, 2014-07, Vol.9 (7), p.e102438-e102438

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaReceptor, Erbb-2 - Genetics

ThemaBreast Neoplasms - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(25)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Female
(23)
Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Oncology
(20)
Breast Neoplasms - Pathology
(18)
Breast Cancer
(10)
Middle Aged
(10)
Biological And Medical Sciences
(9)
Breast Neoplasms - Metabolism
(8)
Medical Sciences
(8)
Aged
(7)
Immunohistochemistry
(7)
Tumors
(7)
Carcinoma, Ductal, Breast - Genetics
(6)
Genes, Erbb-2
(6)
Prognosis
(6)
Adult
(5)
Breast Neoplasms - Drug Therapy
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category

The use of breast cancer subtype classification to predict local and distant recurrence. A review

Typical medullary breast carcinomas have a basal/myoepithelial phenotype

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer

Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene

Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome

Expression of fgf and fgf receptor genes in human breast cancer

Low frequency of microsatellite instability in BRCA1 mutated breast tumours

Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability

Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations

Pgp immunochemistry: use with caution: correspondence re: C-H. Kao et al., P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res., 61: 1412-1414, 2001

HER2 gene amplification assay: is CISH an alternative to FISH?

Inflammatory breast carcinoma: towards molecular characterization?

Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?

BRCA1 induces major energetic metabolism reprogramming in breast cancer cells

Aktive Filter

Suchergebnisse filtern